Alkem Laboratories Limited (NSE:ALKEM)
India · Delayed Price · Currency is INR | Market Cap | 675.24B |
| Revenue (ttm) | 138.90B |
| Net Income (ttm) | 23.61B |
| Shares Out | 119.57M |
| EPS (ttm) | 197.46 |
| PE Ratio | 28.60 |
| Forward PE | 28.41 |
| Dividend | 45.00 (0.80%) |
| Ex-Dividend Date | Aug 8, 2025 |
| Volume | 87,926 |
| Average Volume | 178,441 |
| Open | 5,669.00 |
| Previous Close | 5,647.50 |
| Day's Range | 5,638.00 - 5,692.50 |
| 52-Week Range | 4,491.65 - 5,868.00 |
| Beta | 0.32 |
| RSI | 51.44 |
| Earnings Date | Nov 13, 2025 |
About Alkem Laboratories
Alkem Laboratories Limited, a pharmaceutical company, engages in the research and development, manufacture, and sale of pharmaceutical and nutraceutical products in India, the United States, and internationally. The company offers branded generics, generic drugs, active pharmaceutical ingredients, and biosimilars, and nutraceuticals in acute and chronic therapeutic areas comprising anti-infective, gastroenterology, pain management, iron deficiency, diabetology, central nervous system, anti-osteoporosis, gynecology, respiratory, ophthalmology, r... [Read more]
Financial Performance
In 2024, Alkem Laboratories's revenue was 129.65 billion, an increase of 2.34% compared to the previous year's 126.68 billion. Earnings were 21.65 billion, an increase of 20.59%.
Financial StatementsNews
Top stocks to watch today, November 21: TCS, Godrej Properties, JSW Energy, Hyundai Motor India, Alkem Laboratories and more
Indian equities are set for an active start on November 21, 2025, as several companies issued regulatory filings, business updates,...
Alkem Laboratories launches De Simone formulation probiotic ‘DSS’ in India
Alkem Laboratories Ltd. has introduced the DSS probiotic range in India, bringing the globally acclaimed De Simone formulation to the...
Jubilant Foodworks, Voltas & more: Top stocks on brokers' radar today
CLSA downgraded Jubilant Foodworks to underperform, citing missed sales estimates. Jefferies maintained a buy on Voltas despite Q2 misses, while Bernstein upgraded Muthoot Finance to outperform on str...
Nomura bullish on Alkem Labs as company lifts US growth guidance to double digits
Nomura has reiterated its buy rating on Alkem Laboratories with a target price of ₹6,860 per share after the company...
Alkem Labs share price: Nomura maintains buy with Rs 6,860 target price, says broad-based growth to continue
Nomura has reiterated its buy rating on Alkem Laboratories with a target price of ₹6,860 per share after the company...
HSBC raises target price for Alkem Labs following better than expected Q2 results
HSBC has maintained its hold rating on Alkem Laboratories while raising the target price to ₹5,170 per share following a...
Alkem Laboratories Ltd (BOM:539523) Q2 2026 Earnings Call Highlights: Record Revenue and ...
Alkem Laboratories Ltd (BOM:539523) Q2 2026 Earnings Call Highlights: Record Revenue and Strategic Growth Amid Operational Challenges
Q2 2026 Alkem Laboratories Ltd Earnings Call Transcript
Q2 2026 Alkem Laboratories Ltd Earnings Call Transcript
Alkem Laboratories Q2 Results: Revenue jumps 17.2% YoY to Rs 4,001 crore, net profit up 11.1%
Alkem Laboratories has reported a solid year-on-year performance for the September quarter, reflecting consistent demand across key therapeutic areas and...
Alkem Foundation partners with IIT Bombay to set up India’s first advanced immuno-therapeutics & regenerative medicine research centre
Alkem Foundation, the CSR arm of Alkem Laboratories Ltd, has announced a strategic collaboration with the Indian Institute of Technology...
Alkem Laboratories transfers trade generics business to subsidiary Alkem Wellness, effective October 1
Alkem Laboratories Limited announced on Friday, September 26, that it has formally entered into a Business Transfer Agreement with its wholly owned subsidiary, Alkem Wellness Limited, for the transfer...
Alkem Laboratories launches pertuza biosimilar for treatment of HER2-positive breast cancer
Alkem Laboratories has announced the launch of Pertuza injection 420mg/14mL, a pertuzumab biosimilar, in India for the treatment of HER2-positive breast cancer. Developed and manufactured indigenously...
Stocks to watch on August 22: Key brokerage calls on cement, GMR Airports, Wipro, autos, Alkem Labs, Reliance, and HAL
Indian equities are set to trade with stock-specific action on Friday, August 22, as global brokerage commentary highlights opportunities across cement, airports, IT, autos, pharma, and defence. Analy...
Nomura raises target price on Alkem Labs, says valuation attractive on domestic growth and Enzene prospects
Nomura has maintained its buy rating on Alkem Laboratories and raised the target price to ₹6,300, citing a recovery in domestic growth and strong prospects for its subsidiary Enzene as key drivers. Th...
Alkem Labs shares jump 4% as Nomura maintains ‘Buy’ rating with Rs 5,430 target after strong Q1 results
Alkem Labs shares jumped over 4% following Nomura’s reaffirmation of a Buy rating with a target price of ₹5,430. As of 11:04 AM, the shares were trading 4.37% higher at Rs 5,374.00. The brokerage high...
Stocks to watch on brokerages’ radar today, August 13: Minda Corp, Apollo Hospitals, Alkem Labs, Nykaa, Zydus Lifesciences, HAL, ONGC, NHPC, Honasa, Paytm
Brokerages have issued fresh calls and revised targets for several key companies, with updates spanning the auto ancillary, healthcare, pharma, defence, energy, and consumer sectors. Minda Corp share:...
Alkem Laboratories shares jump 6% on strong Q1 results
Alkem Laboratories’ stock jumped over 6% after the pharma major delivered an impressive set of numbers for the quarter ended June 30, 2025, driven by robust domestic and international performance. As ...
Alkem Laboratories Q1 Results: Revenue jumps 11.2% YoY to Rs 3,371 crore, net profit up Rs 21.45% YoY
Alkem Laboratories has delivered a strong set of numbers for the first quarter of FY26, with growth across revenue, profit, and operational performance. The company reported a consolidated net profit ...
Alkem Labs shares trade lower after Rs 856 crore block deal
Shares of Alkem Laboratories came into focus on Tuesday following a large block deal worth ₹856.39 crore executed on the BSE. The transaction involved the exchange of approximately 17.49 lakh shares a...
Alkem Labs in focus as promoter Jayanti Sinha to sell 1.42 percent stake via Rs 825 crore block deal
Shares of Alkem Laboratories will be in focus today as a large block deal is expected on the counter. According to deal terms, promoter entity Jayanti Sinha is likely to sell a 1.42 percent stake in t...
Stocks to watch on May 30: Bajaj Auto, Ola Electric, Samvardhana Motherson, Suzlon, Alkem Labs in focus after key brokerage calls
Brokerage firms released fresh research notes on select Indian stocks ahead of market action on May 30. The reports cover Q4FY25 earnings trends, management commentary, and sector outlook across auto,...
Nomura maintains ‘Buy’ on Alkem Labs; expects Semaglutide launch to drive future growth
Nomura has reiterated its Buy rating on Alkem Labs with a target price of ₹5,430, viewing the Q4FY25 earnings as largely in line on sales, though EBITDA and PAT came in 2% and 6% below estimates, resp...
Jefferies maintains ‘Underperform’ on Alkem Labs and cuts target price to Rs 4,460 on margin concerns
Jefferies has maintained its Underperform rating on Alkem Labs and cut its target price to ₹4,460 after the company’s Q4 earnings missed estimates on lower margins. After 18 months of margin improveme...
Stocks in focus on May 29: Bajaj Auto, Suzlon Energy, Alkem Labs, SJVN among 40 firms to report Q4 results
As the Q4FY25 earnings season nears its conclusion, Thursday, May 29, will be a key day for several mid- and large-cap companies. A total of 40 listed firms are scheduled to release their quarterly fi...
Alkem Laboratories to acquire 100% stake in Bombay Ortho Industries
Alkem Laboratories has announced that its wholly owned subsidiary, Alkem Medtech Private Limited, has signed a definitive agreement to acquire a 100% stake in Bombay Ortho Industries Private Limited. ...